XML 41 R28.htm IDEA: XBRL DOCUMENT
v3.23.1

Accrued Expenses and Other Current Liabilities (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Payables and Accruals [Abstract] |
Schedule of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consist of the following:
|  | March 31, |  |  | December 31, |
|  | 2023 |  |  | 2022 |
|  | (in thousands) |
Vaxcyte-related accrual under Vaxcyte Supply Agreement |  | $ | 5,274 |  |  | $ | 4,830 |
CMO-related accrual |  |  | 2,404 |  |  |  | 3,900 |
Clinical trials-related accrual |  |  | 2,524 |  |  |  | 2,954 |
Other |  |  | 2,191 |  |  |  | 3,080 |
Total accrued expenses and other current liabilities |  | $ | 12,393 |  |  | $ | 14,764 |

X
- Definition Schedule of accrued liabilities and other liabilities disclosure, current. + References No definition available. + Details
Name: | stro_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTableTextBlock
Namespace Prefix: | stro_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration